These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19264817)

  • 1. Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone.
    Kuloglu M; Ekinci O; Caykoylu A
    J Psychopharmacol; 2010 Apr; 24(4):627-8. PubMed ID: 19264817
    [No Abstract]   [Full Text] [Related]  

  • 2. Buspirone to improve compliance in venlafaxine-induced movement disorder.
    Pavlovic ZM
    Int J Neuropsychopharmacol; 2004 Dec; 7(4):523-4. PubMed ID: 15383159
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report.
    Sabuncuoglu O; Ekinci O; Berkem M
    Spec Care Dentist; 2009; 29(5):215-7. PubMed ID: 19740153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoxetine-Induced Sleep Bruxism Rapidly Treated With Once-Nightly Dosing of Buspirone in a 6-Year-Old Girl.
    Akbaş B; Bilgiç A
    Clin Neuropharmacol; 2018; 41(5):197-198. PubMed ID: 29979192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buspirone as an antidote to venlafaxine-induced bruxism.
    Jaffee MS; Bostwick JM
    Psychosomatics; 2000; 41(6):535-6. PubMed ID: 11110119
    [No Abstract]   [Full Text] [Related]  

  • 7. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT; Jones L; Chamberlain JC
    J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract]   [Full Text] [Related]  

  • 8. Citalopram-induced bruxism.
    Wise M
    Br J Psychiatry; 2001 Feb; 178():182. PubMed ID: 11157444
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA; Hanwella R
    Int Clin Psychopharmacol; 2012 Jan; 27(1):8-16. PubMed ID: 21971532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient outcomes with education, drug therapy, and support: a study of venlafaxine ER-treated outpatients with major depressive disorder.
    Lobello K; Reddy S; Musgnung J; Pedersen R; Ninan PT
    Psychopharmacol Bull; 2010; 43(2):28-44. PubMed ID: 21052041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine.
    Vaccaro M; Borgia F; Barbuzza O; Guarneri B
    Br J Dermatol; 2007 Oct; 157(4):822-4. PubMed ID: 17655739
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hypertriglyceridemia secondary to venlafaxine and fluoxetine.
    Teitelbaum M
    Psychosomatics; 2001; 42(5):440-1. PubMed ID: 11739916
    [No Abstract]   [Full Text] [Related]  

  • 14. Paroxetine-induced severe sleep bruxism successfully treated with buspirone.
    Milanlioglu A
    Clinics (Sao Paulo); 2012; 67(2):191-2. PubMed ID: 22358247
    [No Abstract]   [Full Text] [Related]  

  • 15. Duloxetine-induced nocturnal bruxism resolved by buspirone: case report.
    Albayrak Y; Ekinci O
    Clin Neuropharmacol; 2011; 34(4):137-8. PubMed ID: 21768799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML; Garfield LD; Teitelbaum S; Civitelli R; Mulsant BH; Reynolds CF; Dixon D; Doré P; Lenze EJ
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine-induced hyponatremia.
    Gupta AK; Saravay SM
    J Clin Psychopharmacol; 1997 Jun; 17(3):223-5. PubMed ID: 9169969
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.